Evidence map›Paper›PMID 29346398›Full record

ArticlePloS one2018

Dual function of EDTA with silver nanoparticles for root canal treatment-A novel modification.

Juan M Martinez-Andrade, Miguel Avalos-Borja, Alfredo R Vilchis-Nestor, Luis O Sanchez-Vargas, Ernestina Castro-Longoria

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Antibiotics (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Nanomaterials Application in Endodontics.Materials (Basel, Switzerland) · 2021
    Review
  6. Nanoparticles in Dentistry: A Comprehensive Review.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Application of Antimicrobial Nanoparticles in Dentistry.Molecules (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Juan M Martinez-AndradeDepartamento de Microbiología, Centro de Investigación Científica y de Educación Superior de Ensenada (CICESE), Ensenada, Baja California, México.
Miguel Avalos-BorjaLaboratorio Nacional de Nanociencias y Nanotecnología, Instituto Potosino de Investigación Científica y Tecnológica (IPICyT), San Luis Potosí, San Luis Potosí, México.
Alfredo R Vilchis-NestorCentro Conjunto de Investigación en Química Sustentable, Universidad Autónoma del Estado de México y Universidad Nacional Autónoma de México (UAEM-UNAM), Estado de México, México.
Luis O Sanchez-VargasFacultad de Estomatología, Universidad Autónoma de San Luis Potosí (UASLP), San Luis Potosí, San Luis Potosí, México.
Ernestina Castro-LongoriaDepartamento de Microbiología, Centro de Investigación Científica y de Educación Superior de Ensenada (CICESE), Ensenada, Baja California, México.ORCID 0000-0002-7464-8964
Centro de Investigación Científica y de Educación Superior de Ensenada · MXAutonomous University of San Luis Potosí · MXInstitute for Scientific and Technological Research · MXUniversidad Autónoma del Estado de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chelating and antimicrobial capacity of a novel modification of 17% EDTA with silver nanoparticles (AgNPs) (EDTA-AgNPs) was evaluated in-vitro for root canal treatment (RCT). The EDTA-AgNPs solution was characterized by UV-Vis spectroscopy, ζ-potential and high-resolution transmission electron microscopy (HRTEM). Antimicrobial capacity was evaluated against Candida albicans and Staphylococcus aureus in planktonic and biofilm cells by broth macrodilution (24 h) and XTT assays, (1, 10 and 30 min) respectively. The chelating capacity of EDTA-AgNPs was assessed indirectly (smear layer removal) and directly (demineralizing effect) in bovine dentin at two silver concentrations, 16 and 512 μg/ml at 1 and 10 minutes of exposure time. Smear layer removal was evaluated by atomic force microscopy (AFM) and scanning electron microscopy (SEM). The demineralizing effect was determined by atomic absorption spectroscopy (AAS), microhardness test (MH) and X-ray diffractometer (XRD). Synthesized AgNPs were quasi-spherical in shape with an average size of 13.09 ± 8.05 nm. 17% EDTA-AgNPs was effective to inhibit C. albicans and S. aureus in planktonic and biofilm cultures. The smear layer removal and demineralizing effect were similar between 17% EDTA-AgNPs and 17% EDTA treatments. The 17% EDTA-AgNPs solution proved to be an effective antimicrobial agent, and has a similar chelating capacity to 17% EDTA alone. These in-vitro studies strongly suggest that EDTA-AgNPs could be used for effective smear layer removal, having an antimicrobial effect at the same time during RCT.

Indexed as

Root Canal TherapyAnimalsBiofilmsCandida albicansCattleEdetic AcidMetal NanoparticlesMicrobial Sensitivity TestsMicroscopy, Atomic ForceMicroscopy, Electron, ScanningSilverSpectrophotometry, AtomicStaphylococcus aureusX-Ray DiffractionEdetic AcidSilver

Identifiers

PMID29346398
PMCPMC5773103
OpenAlexW2783499830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.